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Langerhans islet transplantation is a much less invasive approach compared with the pancreas transplantation to
‘cure’ diabetes. However, destruction of transplanted islets by the immune system is an impediment for a successful
treatment. Chemical grafting of monomethoxy poly(ethylene glycol) onto pancreatic islet capsule is a novel
approach in islet immunoisolation. The aim of this study was to determine an optimized condition for grafting of
monomethoxy poly(ethylene glycol) succinimidyl propionate (mPEG-SPA) on islets capsule. Independent variables
such as reaction time, the percentage of longer mPEG in the mixture, and polymer concentration were optimized
using a three-factor, three-level Box-Behnken statistical design. The dependent variable was IL-2 (interleukin-2)
secretion of lymphocytes co-cultured with PEGylated or uncoated control islets for 7 days co-culturing. A
mathematical relationship is obtained which explained the main and quadratic effects and the interaction of factors
which affected IL-2 secretion. Response surface methodology predicted the optimized values of reaction time, the
percentage of longer mPEG in the mixture, and polymer concentration of 60 min to be 63.7% mPEG10 and 22 mg/mL,
respectively, for the minimization of the secreted IL-2 as response. Islets which were PEGylated at this condition were
transplanted to diabetic rats. The modified islets could survive for 24 days without the aid of any immunosuppressive
drugs and it is the longest survival date reported so far. However, free islets (unmodified islets as control) are
completely destroyed within 7 days. These results strongly suggest that this new protocol provides an effective clinical
means of decreasing transplanted islet immunogenicity.
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Diabetes mellitus type I, insulin dependent diabetes
mellitus (IDDM), is an autoimmune disorder which
leads to the destruction of insulin-producing pancreatic
islets. Current therapies for IDDM include exogenous
insulin therapy and pancreas transplantation. Although
daily administration of insulin is the standard protocol,
deficient control of blood glucose leads to severe com-
plications, such as heart disease, nephropathy, and
hypoglycemia (Hill 2004). Currently, pancreas trans-
plantation is the only available option to ‘cure’ diabetes,* Correspondence: evf@modares.ac.ir
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reproduction in any medium, provided the origbut this procedure requires major surgery and lifelong
immunosuppression therapy. Langerhans islet trans-
plantation is another approach to cure diabetes which is
much less invasive (Lakey et al. 2006). However, immune
destruction of transplanted islets is an impediment for a
successful procedure (Devos et al. 2005). There are two
major approaches to immunoisolate islets: islet encapsu-
lation and surface modification (Lee and Byun 2010).
Conjugation of polyethylene glycol (PEG) to the surface
of Langerhans islets, islet PEGylation, is another novel
approach for immunoprotection of the islets (Panza
et al. 2000; Scott and Chen 2004). This strategy was ori-
ginally applied for surface modification of red blood cells
(RBC) in which PEG covalently attaches to the surface
amino acids of the RBC, thereby masking the major and
minor blood group antigens from hosting antibodieser. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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et al. 2006; Scott and Murad 1998). Based on such en-
couraging results, PEGylation method was employed for
camouflaging pancreatic islets without affecting their
viability and functionality. PEGylation also does not in-
crease islets volume (Panza et al. 2000; Lee et al.
2002; Xie et al. 2005). PEGylation reaction happens
when the functional group of the polymer, succinimidyl
group of mPEG-succinimidyl propionic acid (mPEG-SPA)
in this case, conjugates to the amine groups of the colla-
gen matrix of islets, thereby forms a stable amide bond
(Jang et al. 2004).
For completing the coverage of the islets surface by
PEG without any adverse effects, the reaction factors
should be optimized. Contributing factors that affect
preceding the reaction are the molecular weight of PEG,
polymer concentration, and reaction time (Roberts et al.
2002). Nowadays, many statistical approaches have been
known as useful techniques to optimize the process
these variables. Box-Behnken or modified central com-
posite design is an independent and nearly rotatable
quadratic design, in which the treatment combinations
are at the midpoints of the edges of the process space
and at the center (Box et al. 1967). Since 1960, Box-
Behnken designs have been very popular with experi-
menters wishing to estimate a second-order model in
three or four factors. This popularity is due to these
three-level designs’ simplicity and high efficiency.
Among all the response surface methods, this method
requires fewer runs in a three-factor experimental design
(Chung et al. 2007).
At present study, three-level, three-factor experi-
ments was designed by Box-Behnken to observe the
event of parameters influencing on islets PEGylation.
The factors that are considered to have an effect on
PEGylation are (a) reaction time, (b) the percentage
of longer mPEG in the mixture, and (c) polymer con-
centration. The dependent variable is the amount of IL-
2 (interleukin-2) secreted during co-culturing of islets
with lymphocytes (Y).
Methods
Isolation of pancreatic islets and PEGylation
The pancreatic islets were obtained from male Wistar
rats (250 to 300 g) as described by Lacy and Kostinovsky
(1967). Briefly, 10 mL of Hanks’ balanced salt solution
(HBSS) containing 2 mg/mL collaganase type V (Sigma
Chemical Co., St Louis, MO, USA) was injected into the
pancreas. The swollen pancreas was excised and incu-
bated at 37°C for 15 min. The digestion of pancreas
stopped by the addition of 20 mL cold HBSS followed
by shaking for 1 min to mechanical disruption.
Disrupted pancreas was filtrated through 100-μm mesh
to remove other tissues. After washing with HBSScontaining fetal bovine serum (FBS), the isolated islets
were purified by centrifugation in a discontinuous
Histopaque 1.077 (Sigma Chemical Co., St Louis, MO,
USA) gradient and then washed with RPMI-1640 culture
medium (Sigma Chemical Co., St Louis, MO, USA). Is-
lets were segregated by handpicking and finally cultured
overnight in RPMI-1640 medium at 37°C in the humidi-
fied atmosphere containing 5% CO2 to recover.
Activated mPEG (mPEG-SPA) was prepared and charac-
terized as described by Perry and Kwang (2006). For
grafting activated mPEG, purified islets were washed
twice with HBSS (pH 7.4) followed immediately by
suspending in 10 mL HBSS which contained mPEG-
SPA. The suspension was incubated at 37°C in humidified
air containing 5% CO2. After incubation, the PEGylated
islets were washed twice with RPMI and suspended in
culture medium for co-culturing with lymphocytes.
Preparation of splenic lymphocytes
The lymphocyte cells were isolated from the spleen
using Ficoll density gradients (Amersham Bioscience,
Uppsala, Sweden). The spleen was obtained aseptically
from male C57BL/6 mouse. After grinding the spleen in
HBSS, the obtained splenocytes were diluted with 3 mL
HBSS and layered on 4 mL Ficoll carefully. The cell sus-
pension was centrifuged at 400×g for 30 min at 4°C, and
then the opaque interface containing lymphocytes were
transferred into a conical centrifuge tube. After washing
with RPMI, the lymphocytes were isolated. The viability
of the isolated splenic lymphocytes was determined by
staining with trypan blue (Gibco, Paisley, Scotland).
Co-culture of islets with lymphocyte
Thirty islets were co-cultured with the 5 × 105 lympho-
cytes in each well of 96-well plate in 200 μL of RPMI
medium containing 10% FBS in 95% O2 and 5% CO2 for
7 days at 37°C. To determine the release of IL-2 from
lymphocytes against the islets, 100 μL of the medium
was sampled on the fifth day of culturing and frozen
at −70°C for subsequent measurement. The same
amount of fresh medium was refilled into each well, so
the volume of culture medium was maintained at 200 μL/
well. Mouse IL-2 was measured by enzyme-linked im-
munosorbent assay using commercial kit (E-bioscience,
San Diego, CA, USA).
Box-Behnken statistical design for optimization
A three-factor, three-level Box-Behnken design was used
to optimize and evaluate the main effects, interaction ef-
fects, and quadratic effects. This design is suitable for
exploring quadratic response surface and constructing
second-order polynomial models. This cubic design is
given by a set of points at the midpoint of each edge of
multidimensional cube and a center point replicate
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generated quadratic model is given in Equation 1:
Y ¼ b0 þ b1Aþ b2Bþ b3C þ b12ABþ b13AC
þb23BC þ b11A2 þ b22B2 þ b33C2;
ð1Þ
where Y is the measured response associated with each
factor level combination; b0 is an intercept; b1 to b33 are
the regression coefficients; A, B, and C are the independ-
ent variables. The dependent and independent variables
are shown in Table 1. These high, medium, and low
levels are selected from the preliminary experiments.
After generating the polynomial equations relating the
dependent and independent variables presented in
Table 1, the process was optimized for the desired re-
sponse. Optimization was performed to obtain the levels
A, B and, C, which minimized Y.
Allotransplantation of PEGylated islets
Inbred male Wistar rats were rendered diabetic with a
single intraperitoneal injection of 45 mg/kg of strep-
tozotocin (Sigma) freshly dissolved in citrate buffer
(pH 4.5) 3 days before transplantation. Only rats with
stable non-fasting blood glucose levels of >350 mg/dLTable 1 Variables and Box-Behnken design and the
obtained and predicted results















0a 0 0 0 270.47 101.44
1 30 0 16 160.01 159.07
2 30 50 22 145.32 148.88
3 30 100 16 125.48 126.39
4 30 50 10 130.10 126.57
5 45 100 22 103.45 98.98
6 45 100 10 100.65 103.28
7 45 0 22 126.17 123.55
8 45 0 10 103.49 107.96
9b 45 50 16 105.32 101.44
10b 45 50 16 115.93 106.19
11b 45 50 16 100.21 101.44
12b 45 50 16 110.73 106.19
13b 45 50 16 98.79 101.44
14 60 0 16 93.72 92.81
15 60 50 10 98.60 95.04
16 60 100 16 95.30 96.24
17 60 50 22 80.47 84.00
aRefers that the experiment was done with untreated (free) islets; bThe center
points for calculating experimental error.over three continuous measurements were considered
diabetic and used for the islet allotransplantation. The
blood glucose levels were measured in the tail venous
blood using a portable blood glucose meter (Optimum,
MediSense, Maiden Head, UK).
For islets transplantation, streptozotocin-induced dia-
betic recipients were anesthetized by intraperitoneal
injection of 90 mg/kg ketamine with 8 mg/kg xylazine. The
left kidneys were exposed through a small incision and
capsulotomy was performed on the surface of the left kid-
ney, then the unmodified islets or PEGylated islets (1,200
islets/recipient) were injected. After allotransplantation, the
glucose levels of non-fasting recipients were measured
daily between 10:00 a.m. and 12:00 a.m. Transplantations
were considered successful if the blood glucose levels
returned to normal level of <120 mg/dL for two consecu-
tive days after islet transplantation, and islet rejection was
supposed to have occurred if two consecutive blood glu-
cose levels exceeded 200 mg/dL.
Statistical analysis
Islet survival data are expressed as median ± SD and an-
alyzed using SPSS v.16.0 statistical software. For com-
parison of the mean values, independent variable t test
was used. Significance was determined by one sample t
test considering the p value <0.05.
Results and discussion
Box-Behnken statistical design for optimization
The Box-Behnken design for the three factors offers
fewer experimental runs as compared with that of cen-
tral composite models, which require 20 runs (Box et al.
1967). The dependent and independent variables for
design-generated experimental runs and the amount of
secreted IL-2 for each 18 tests, consisting of 17 runs pre-
dicted by software plus a control run, are given in
Table 1. Table 2 indicates the analysis of variance of the
obtained results. The factors with p value <0.05 areTable 2 Analysis of variance table
Factors p value F df Sum of squares
Reaction time(min) <0.0001 177.16 1 4647.44
mPEG10in mixture (%) 0.0099 16.31 1 427.93
Polymer conc.(mg/mL) 0.1800 2.43 1 63.68
AB 0.0168 12.43 1 325.98
AC 0.0226 10.60 1 278.06
A2 0.0085 17.61 1 461.92
B2 0.0741 5.07 1 133.03
Model 0.0010 27.12 9 6402.22
Residual - - 5 131.17
Lack of fit 0.2572 3.04 3 107.58
Figure 1 Parity plot showing the distribution of predicted vs. experimental values of IL-2 secretion. The bar in the left hand side of the
figure indicates the changes from low (blue) to high (red) values.
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all experiments resulted in decreasing the IL-2 secretion
from lymphocytes which is the result of shielding effect
of mPEG-SPA. Jang et al. demonstrated that the lympho-
cytes co-cultured with PEGylated islets could not affect
their viability. Their findings suggested that PEGylation
can attenuate the immunogenicity of islets via blocking
the recognition of immune cells (Jang et al. 2004). The
results in Table 2 indicate that these three factors had a
profound effect on the islet masking with mPEG-SPA. At
experimental runs of 5, 6, 8, 9, and 13 to 17, the IL-2 se-
cretion decreased 60% more compared to the control run.
The mathematical relationship in the form of polyno-
mial equation for measured response, Y, obtained with
statistical package Design Expert (version 7, State Ease
Inc., Minneapolis, MN, USA) is in (Equation 2)
Y ¼ 101:44 24:10A 7:31Bþ 2:82C
þ9:03AB 8:34AC þ 11:19A2 þ 6B2
ð2Þ
This polynomial equation represents the quantitative
effect of the process variable (A, B, and C) and their in-
teractions on the response Y. The model F value is 27.12
and implies that the model is significant.
The values of coefficients A, B, and C are related to
the effect of these variables on the response. Coefficients
with more than 1 factor term and those with higher
order terms represent interaction terms and quadratic
relationship, respectively. A positive value represents a
favorable effect, while the negative value indicates an ad-
verse effect. In this case A, B, AB, and AC have the main
effect on the response. The values of A, B, and C were
substituted in the equation to obtain the theoretical
values of Y. In Figure 1, the parity chart, the experimen-
tal response values are plotted versus the predictedresponse values. The points are scattered around the di-
agonal line which indicate the predicted values and the
observed values are in good agreement.
Figure 2 is the 2 and 3D views of the main effects of
interaction. As it is shown in (a) of Figure 2, IL-2 secre-
tion decreased sharply by increasing time which is com-
pletely presented in Figure 3. As shown in (a) of
Figure 2, at low reaction times, IL-2 secretion decreased
by increasing the percentage of 10 kDa mPEG in the
mixture due to the higher shielding effect of long chain
polymers on the surface of islets. But at high reaction
time, increasing the percentage of 10 kDa mPEG in the
mixture of mPEGs (5 and 10 kDa) from 0 to 100 caused
an initial decrease in IL-2 secretion with a minimum
point occurring at 63.68%. The molecular weight of lin-
ear polymers links the chemical and biophysical basis of
immunocamouflaging. It is postulated that mPEG with
higher molecular weight may be more suitable for sur-
face coating of cells due to its high shielding effect. But
Barrou et al. showed that the viscosity of 35 kDa PEG is
too high for physiological use. Their results indicated that
the optimal chain length at 1.5 mM of PEG is 20 kDa
(Neuzillet et al. 2006). The biophysical camouflage of the
surface charge is directly proportional to the molecular
weight of the grafted polymer. Electrophoretic mobility
decreased due to a shift of the shear plane from the sur-
face towards a region of decreased zeta potential. This
shift was proportional to the hydrodynamic thickness of
the polymer layer and was best achieved with long chain
polymers (Lee and Scott 2010). The Flory radii (RF root
mean square of end to end length of the polymer chain
and radius of gyration) of the covalently bound polymers
can be calculated by this formula: RF = aN
(3/5) (a = 3.5 Å,
N = number of monomers) (Lee and Scott 2010).
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Figure 2 Response surface and contour plots which show the effect of (a) time and mPEG10 percent and (b) time and polymer
concentration on response Y.
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polymers, because of their higher water absorption, higher
volume occupation, and movement in larger space, mask
the cell surface charges and antigens better, which causes
less stimulation of the immune system.
The steric exclusion effect of the grafted polymer
chains primarily prevents protein adsorption (Lee and
Scott 2010). This effect maximized when chains are
grafted at higher density, i.e., with small separation be-
tween chains. But the high-density grafting is difficult to
achieve with polymers having a large gyration radius
(Lee and Scott 2010). When long and short polymers are
attached onto surface together, higher density can be
achieved. Therefore, this effect can explain why the mini-
mum point occurred at 63.68%. But it should be men-
tioned that a 5-kDamPEG derivative will have twice the
number of reactive groups as a 10-kDa mPEG derivative
at the same mass concentration.
The interaction of reaction time and polymer concentra-
tion on the immunological response of PEGylated islets isshown in Figure 2b. When polymer concentration in-
creased, the IL-2 secretion decreased in slight incline which
is presented in the figure. In our previous work, the surface
of the Langerhans islets was coated by cyanuric chloride-
activated methoxy(polyethylene glycol). The effect of poly-
mer coating, at two different reaction times and polymer
concentrations, was investigated. When polymer concen-
tration and reaction time increased to 40 mg/mL and
90 min, respectively; the immunological response to
PEGylated islets decreased to 76.5%, compared to un-
treated islets (Hashemi-Najafabadi et al. 2007). Recently,
we reported that by increasing mPEG-succinimidyl car-
bonate (5 kDa) concentration up to 22 mg/mL, islets were
protected from immune cells more efficiently without af-
fecting their viability and functionality (Aghajani-Lazarjani
et al. 2010).
According to the correlation given by Equation 2,
the minimum IL-2 secretion is 83.5622 pg/mL which is
expected to be achieved when reaction time, the per-
centage of mPEG10 in the mixture, and polymer
Figure 3 One-factor plot of reaction time effect on
IL-2 secretion.
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spectively. The validation experiments were carried out
under optimized conditions, and IL-2 secretion was 80.51
± 6.34 pg/mL. It is in good agreement with the statistically
predicted value and confirms the model’s authenticity.
Lee et al. (2002) reported that the optimized concentra-
tion of mPEG-SPA (5kDa) and reaction time were 0.25%
w/v and 1 h, respectively. They used one-factor-at-a-timeFigure 4 Changes in non-fasting blood glucose levels of streptozotoc
of streptozotocin-induced diabetic rat after transplantation of unmodified i
failure was defined as two consecutive plasma glucose concentrations ≥20method to optimize the reaction condition, so the effect of
the factor interactions was not investigated.
Transplantation of islets
To investigate the effect of PEGylation on islet survival,
PEGylated islets obtained at the optimum condition, and
unmodified islets (control) were transplanted under the
capsule of left kidney. Figure 4 shows the changes in
non-fasting blood glucose levels of recipients after trans-
plantation. Six hours after transplantation, the first
measurement of blood glucose was taken, and sudden
decrease was observed in the case of unmodified islets.
The same observation was reported by Teramura and
Iwata (2009). These results indicate that the islets were
damaged and large amounts of insulin released into the
blood, so blood glucose decreased transiently.
Unmodified islets survived for 6.3 ± 1.52 days (mean ±
SD; n = 3). In contrast, normal glycemia was achieved
on transplantation of PEGylated islets for 24.0 ± 3.7 days
(mean ± SD; n = 3).
Lee et al. reported that the PEGylated islets survive for
12 ± 2.6 days. In their research, 12.5 mg/mL mPEG-SPA
(5 kDa) was added to the islets solution. The incubation
lasted for 1 h at 37°C in a humidified 5% CO2 atmos-
phere (Jang et al. 2004), which means that the one-layer
PEG is insufficient as immunocamouflage. In another
study, they showed triple PEGylations method for islet
PEGylation. Although they got long survival time for
three recipients, more than 100 days, the median sur-
vival time was only 19.0 ± 45.6 days (Lee et al. 2007).in-induced diabetic rat. Changes in non-fasting blood glucose levels
slets as control (black circles) and PEGylated islets (black squres). Graft
0 mg/dL.
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mPEG-SPA could attach covalently on the surface of
Langerhans islets without volume increase and cytotox-
icity, but the in vivo survival time of PEGylated islets is
not long enough. So, recent researches’ tendency is to
lengthen it. Different approaches have been studied
so far such as cyclosporine administration and triple
PEGylations method. The aim of this study was to prolong
PEGylated islets survival time; therefore, the optimization
of PEGylation reaction was studied. The variables of
PEGylation reaction were optimized using a response sur-
face method, the Box-Behnken design. The reaction vari-
ables such as reaction time, percentage of mPEG10 in the
mixture, and polymer concentration showed a significant
effect on IL-2 secretion from lymphocytes co-cultured
with PEGylated islets. The optimum value of these was
found to be 60 min, 63.7%, and 22 mg/mL, respectively.
The optimized condition was applied for PEGylation, and
PEGylated islets were transplanted under the kidney cap-
sule of diabetic rats. The in vivo survival time of
PEGylated islets increased to 24.0 ± 3.7 days without using
immunosuppressive drugs. Thus, single PEGylation at
optimum condition intensified islets camouflaging.
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